Zhenyi Medical Subsidiaries Win Dual Awards, Highlighting Innovation Strength!

Jiangsu Trulive Medtech Co., Ltd. focuses on the field of cardiovascular diseases, which have extremely high mortality and disability rates and remain a gap in the Chinese-produced market. Its business comprehensively covers multiple interventional treatment areas such as heart valves, peripherals, and coronary arteries. It is a platform enterprise that takes the lead in providing one-stop innovative solutions for blood flow management on a global scale. With strong research and development capabilities and a senior, complete operational team, Trulive Medtech has developed high-quality Chinese-produced medical devices with independent intellectual property rights and comprehensive solutions, filling the void in China’s high-end cardiovascular interventional medical device market. This provides Chinese doctors and patients with more advanced and diverse treatment options. Meanwhile, Trulive Medtech, rooted in China and expanding globally, continues to upgrade with technological innovation and development, accelerating the expansion of its global commercial network. In many细分 markets within the cardiovascular intervention field that have long been monopolized by imported products, it offers "Chinese solutions" and contributes "Chinese wisdom."